Mar 8, 2009 | Posted by: lastword
Full story: www.mddailyrecord.com![]()
Osiris Therapeutics Inc., of Columbia, said its fourth-quarter loss narrowed on a boost in revenue from development partnerships and lower costs.
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
|
|
Jan '10 | stem cell stocks | 1 |